HEALTHY EXTRACTS INC. (HYEX): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
HEALTHY EXTRACTS INC. (HYEX) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. HEALTHY EXTRACTS INC. - Form 8-K SEC filing 0001630176 false 0001630176 2026-07-01 2026-07-01 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Dat
How this was made
The 30-second read
Why it matters
The immediate vacancy of President and COO can affect near-term decision-making, staffing, and execution cadence; absent replacement details, the market may treat it as governance risk.
Market read
This is a fresh, company-specific leadership change disclosed via SEC filing, which can drive short-term volatility and prompts for succession follow-through.
What to watch
Traders should watch for a follow-on 8-K naming interim officers, board appointments, or any stated reason for departure that could change the risk assessment.
Background
The company filed an 8-K under Item 5.02 for officer/director departure and related compensatory arrangements.
Ticker impact
Healthy Extracts disclosed Kevin “Duke” Pitts’ resignation as President, COO, and board member, leaving the President/COO roles vacant.
Likely modest downside/volatility risk until the company clarifies interim leadership and succession.
The filing confirms a multi-role resignation and immediate vacancy, but provides no replacement, timeline, or operational rationale—so the market may price uncertainty rather than a specific positive/negative fundamental change.
Market effects
Limited direct sector read-through; this is company-specific governance/management risk rather than an industry-wide catalyst.
No clear regional spillover indicated by the filing.
No global macro or cross-border transaction disclosed.
Counterpoint
The resignation could be routine or planned, and the company may already have interim coverage not described in the brief 8-K.
Key entities
- issuerHealthy Extracts Inc.
Nevada registrant that filed the 8-K disclosing officer/director departure.
- personKevin “Duke” Pitts
Resigned as President, Chief Operating Officer, and board member effective July 1, 2026.
- personDonald Swanson
CEO who signed the filing on July 6, 2026.
